doxacurium Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
neuromuscular blocking agents with rigid structure 2974 133814-18-3

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • doxacurium
  • doxacurium chloride
  • BW-A938U
according to Unlisted Drugs, BW-A938U is a bis-benzylisoquinolinium diester and a highly potent neuromuscular blocker
  • Molecular weight: 1035.24
  • Formula: C56H78N2O16
  • CLOGP: 1.04
  • LIPINSKI: 2
  • HAC: 18
  • HDO: 0
  • TPSA: 163.36
  • ALOGS: -7.09
  • ROTB: 29

  • Status: OFM

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

None

ADMET properties:

PropertyValueReference
MRTD (Maximum Recommended Therapeutic Daily Dose) 0.05 ┬ÁM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD
Vd (Volume of distribution) 0.22 L/kg Lombardo F, Berellini G, Obach RS
CL (Clearance) 2.70 mL/min/kg Lombardo F, Berellini G, Obach RS
fu (Fraction unbound in plasma) 0.53 % Lombardo F, Berellini G, Obach RS
t_half (Half-life) 1.70 hours Lombardo F, Berellini G, Obach RS

Approvals:

DateAgencyCompanyOrphan
March 7, 1991 FDA

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

Pharmacologic Action:

SourceCodeDescription
ATC M03AC07 MUSCULO-SKELETAL SYSTEM
MUSCLE RELAXANTS
MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Other quaternary ammonium compounds
MeSH PA D009465 Neuromuscular Agents
MeSH PA D009466 Neuromuscular Blocking Agents
MeSH PA D003473 Neuromuscular Nondepolarizing Agents
MeSH PA D018373 Peripheral Nervous System Agents
CHEBI has role CHEBI:51371 muscle relaxant

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Muscle relaxation, function indication 11977004
General anesthesia indication 50697003
Skeletal Muscle Relaxation for Endotracheal Intubation indication
Disorder of acid-base balance contraindication 26436007
Myasthenia gravis contraindication 91637004 DOID:437
Disorder of electrolytes contraindication 237840007
Renal Impairment associated with Kidney Transplant contraindication
Hepatic Impairment associated with Hepatic Transplant contraindication

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Acetylcholine receptor Ion channel ANTAGONIST WOMBAT-PK CHEMBL
Neuronal acetylcholine receptor subunit alpha-2 Ion channel WOMBAT-PK
Muscarinic acetylcholine receptor M2 GPCR WOMBAT-PK

External reference:

IDSource
4020524 VUID
N0000148242 NUI
C0058716 UMLSCUI
D00760 KEGG_DRUG
108458009 SNOMEDCT_US
4020524 VANDF
d00957 MMSL
23651 RXNORM
372496007 SNOMEDCT_US
013424 NDDF
DB01135 DRUGBANK_ID
M78TVM3G5Z UNII
6205 INN_ID
83348-52-1 SECONDARY_CAS_RN
CHEBI:4706 CHEBI
CHEMBL1237099 ChEMBL_ID
CHEMBL1237123 ChEMBL_ID
60169 PUBCHEM_CID
C049429 MESH_SUPPLEMENTAL_RECORD_UI

Pharmaceutical products:

None